SM
CRXT

Sabby Management’s Clarus Therapeutics Holdings, Inc. Common Stock CRXT Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-146,900
Closed -$5K 117
2022
Q3
$5K Sell
146,900
-53,100
-27% -$1.81K 0.01% 81
2022
Q2
$76K Buy
+200,000
New +$76K 0.05% 55